Free Trial
→ Watch This Robotics Demo Before July 23rd (From Brownstone Research) (Ad) Buy CTXR Stock  Free CTXR Stock Alerts

Citius Pharmaceuticals (CTXR) SEC Filings & 10K Form

Citius Pharmaceuticals logo
$0.77 +0.05 (+6.51%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.77 +0.00 (+0.13%)
As of 05/2/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Citius Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/28/2025
6:30 AM		Citius Pharmaceuticals (Filer)
Form DEF 14A
04/28/2025
6:32 AM		Citius Pharmaceuticals (Filer)
Form DEFA14A
04/02/2025
6:27 AM		Citius Pharmaceuticals (Filer)
Form 424B5
03/10/2025
3:30 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:30 PM		Citius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/06/2025
8:20 AM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:05 PM		Citius Pharmaceuticals (Filer)
Form DEF 14A
01/27/2025
3:07 PM		Citius Pharmaceuticals (Filer)
Form DEFA14A
01/16/2025
3:30 PM		Citius Pharmaceuticals (Filer)
Form PRE 14A
01/08/2025
3:05 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
8:00 AM		Citius Pharmaceuticals (Filer)
Form 424B5
01/07/2025
8:11 AM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:10 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:00 PM		Citius Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/20/2024
3:30 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:05 PM		Citius Pharmaceuticals (Subject)
Mazur Leonard L (Filed by)
Form SC 13D/A
11/25/2024
4:15 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:15 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:30 AM		Citius Pharmaceuticals (Filer)
Form 424B5
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
MCGRATH DENNIS M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Dutia Suren G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Czuczman Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Bartushak Jaime (Reporting)
Citius Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Smith Robert Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
4:25 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
4:26 PM		Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
4:27 PM		Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
7:30 AM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
4:26 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:15 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
3:01 PM		Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:01 PM		Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:34 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Pharmaceuticals (Filed by)
Form SC 13D
08/16/2024
3:35 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
5:19 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:25 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:10 PM		Citius Pharmaceuticals (Filer)
Form 424B5
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
08/12/2024
4:25 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:51 PM		Citius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
8:20 AM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:05 PM		Citius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
1:22 PM		BlackRock Inc. (Filed by)
Citius Pharmaceuticals (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CTXR) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...
Timothy Sykes | Sponsored
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Gold Alert: The Truth About Fort Knox Is Coming
Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...
Golden Portfolio | Sponsored
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
How to invest in Elon Musk’s Optimus before its launch
Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...
InvestorPlace | Sponsored
Trump to solve American wealth loss?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
The collapse has already started
The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...
Investors Alley | Sponsored